Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 6, 2024

https://www.globenewswire.com/news-release/2024/05/06/2876228/0/en/Pulmonx-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq:LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today announced that the Compensation Committee of the Board of Directors of Pulmonx (the “Compensation Committee”) granted inducement awards consisting of a non-statutory stock option to purchase 241,409 shares of common stock and a time-based restricted stock unit award for 125,870 shares of common stock on May 6, 2024 to Mehul Joshi in connection with his appointment as the Chief Financial Officer of Pulmonx in April 2024.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.